Rubra Medicaments reports standalone nil net profit/loss in the March 2021 quarter

Sales decline 52.38% to Rs 0.30 crore

Rubra Medicaments reported no net profit/loss in the quarter ended March 2021 as against net loss of Rs 0.01 crore during the previous quarter ended March 2020. Sales declined 52.38% to Rs 0.30 crore in the quarter ended March 2021 as against Rs 0.63 crore during the previous quarter ended March 2020.

For the full year,net profit declined 66.67% to Rs 0.01 crore in the year ended March 2021 as against Rs 0.03 crore during the previous year ended March 2020. Sales declined 50.51% to Rs 0.49 crore in the year ended March 2021 as against Rs 0.99 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales0.300.63 -52 0.490.99 -51 OPM %0-4.76 -2.041.01 - PBDT0-0.03 100 0.010.01 0 PBT0-0.03 100 0.010.01 0 NP0-0.01 100 0.010.03 -67

Powered by Capital Market - Live News